We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $87.21 · 14 analysts
Stored first · Google News · Yahoo Finance (English)
Henry Schein stock reflects steady health-care distribution business - Ad-hoc-news.de
Henry Schein stock reflects steady health-care distribution business Ad-hoc-news.de
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein Inc. stock outperforms competitors on strong trading day MarketWatch
Multi-year Support for Henry Schein Innovation Laboratory - The Medical University of South Carolina
Multi-year Support for Henry Schein Innovation Laboratory The Medical University of South Carolina
Is Henry Schein’s GoTu Staffing Integration Reshaping Its Services Efficiency Narrative (HSIC)? - simplywall.st
Is Henry Schein’s GoTu Staffing Integration Reshaping Its Services Efficiency Narrative (HSIC)? simplywall.st
Is Now The Time To Look At Buying Henry Schein, Inc. (NASDAQ:HSIC)? - Moomoo
Is Now The Time To Look At Buying Henry Schein, Inc. (NASDAQ:HSIC)? Moomoo
McKesson Stock Is Shrinking, and That's The Point for Owners
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 04. | After market close (AMC) | $1.23 | — | — | $3.38B | — | Scheduled |
| FY2026 Q1 | 2025. 03. 29. | Time TBD | — | $0.88 | — | — | $3.17B | Reported |
| FY2025 Q3 | 2024. 09. 28. | Time TBD | — | $2.3 | — | — | $9.48B | Reported |
| FY2025 Q2 | 2024. 06. 29. | Time TBD | — | $1.52 | — | — | $6.31B | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 07. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2026. 05. 06. | Mizuho | — | Maintain | Neutral → Neutral | — | Mizuho: Neutral |
| 2026. 04. 25. | Morgan Stanley | — | Maintain | Underweight → Underweight | — | Morgan Stanley: Underweight |
| 2026. 04. 16. | BTIG | — | Initiate coverage | — → Neutral | — | BTIG: Neutral |
| 2026. 04. 16. | Citigroup | — | Initiate coverage | — → Buy | — | Citigroup: Buy |
| 2026. 04. 09. | Evercore ISI Group | — | Maintain | Outperform → Outperform | — | Evercore ISI Group: Outperform |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.